ReviewIn vivo (Athens, Greece)

Resumption of Immune Checkpoint Inhibitor Therapy Following Immune-related Adverse Events.

Hirotaka SutoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.